Fatty Acid Oxidation Disorder Market Size & Share, by Type (Long Chain, Short Chain), End User (Hospitals, Clinics, Pharmaceutical Companies) - Global Supply & Demand Analysis & Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5403
  • Published Date: Nov 27, 2023
  • Report Format: PDF, PPT

Companies Dominating the Fatty Acid Oxidation Disorder Landscape

top-features-companies
    • Ultragenyx Pharmaceutical Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Recordati Rare Diseases Inc.
    • Retrophin, Inc.
    • Amicus Therapeutics, Inc.
    • Aeglea BioTherapeutics, Inc.
    • Zogenix, Inc.
    • Homology Medicines, Inc.
    • Censa Pharmaceuticals Inc.
    • Takeda Pharmaceutical Company Limited
    • Regenxbio Inc.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • In 2022, Recordati Rare Diseases acquired EUSA Pharma (UK) Ltd, a global specialty pharmaceutical company focused on rare and niche oncology diseases. The acquisition expanded Recordati Rare Diseases' portfolio of rare disease products and pipeline.
  • In 2023, Recordati Rare Diseases announced the acquisition of the trademark and marketing authorization for Italy of the Telefil® brand (tadalafil). This acquisition will expand Recordati Rare Diseases' presence in the Italian market.

Author Credits:  Smruti Ranjan, Rajrani Baghel


  • Report ID: 5403
  • Published Date: Nov 27, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing demand for healthcare sector is the major factor driving the market growth.

The market size of fatty acid oxidation disorder is anticipated to attain a CAGR of 8% over the forecast period, i.e., 2024-2036.

The major players in the market Ultragenyx Pharmaceutical Inc., Recordati Rare Diseases Inc., Retrophin, Inc., Amicus Therapeutics, Inc., Aeglea BioTherapeutics, Inc., Zogenix, Inc., and others.

The hospitals segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying